Rockwell Medical, Inc operates as a specialty pharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis. The company offers Triferic, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stores; and Calcitriol, an active vitamin D injection for the management of hypocalcemia in patients undergoing chronic hemodialysis.
Read More…
Industry, Sector and Symbol
Industry Electromedical equipment
Sub-IndustryHealth Care Equipment
SectorMedical
Phone248-960-9009
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$63.39 million
Profitability
Miscellaneous
Employees269
Next Earnings Date11/8/2019 (Estimated)
OptionableOptionable
Rockwell Medical (NASDAQ:RMTI) Frequently Asked Questions
What is Rockwell Medical's stock symbol?
Rockwell Medical trades on the NASDAQ under the ticker symbol "RMTI."
How were Rockwell Medical's earnings last quarter?
Rockwell Medical Inc (NASDAQ:RMTI) issued its quarterly earnings results on Thursday, August, 8th. The company reported ($0.18) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.16) by $0.02. The firm earned $14.85 million during the quarter, compared to analyst estimates of $16.42 million. Rockwell Medical had a negative return on equity of 143.68% and a negative net margin of 52.11%. View Rockwell Medical's Earnings History.
When is Rockwell Medical's next earnings date?
What price target have analysts set for RMTI?
4 Wall Street analysts have issued twelve-month target prices for Rockwell Medical's stock. Their predictions range from $10.00 to $12.00. On average, they expect Rockwell Medical's stock price to reach $11.00 in the next year. This suggests a possible upside of 230.3% from the stock's current price. View Analyst Price Targets for Rockwell Medical.
What is the consensus analysts' recommendation for Rockwell Medical?
4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Rockwell Medical in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Rockwell Medical.
Has Rockwell Medical been receiving favorable news coverage?
News headlines about RMTI stock have trended negative on Thursday, according to InfoTrie Sentiment. InfoTrie rates the sentiment of news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Rockwell Medical earned a coverage optimism score of -2.9 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the next several days. View News Stories for Rockwell Medical.
Are investors shorting Rockwell Medical?
Rockwell Medical saw a increase in short interest in the month of August. As of August 15th, there was short interest totalling 7,309,600 shares, an increase of 8.3% from the July 15th total of 6,746,900 shares. Based on an average trading volume of 455,600 shares, the short-interest ratio is currently 16.0 days. Approximately 16.0% of the shares of the company are sold short. View Rockwell Medical's Current Options Chain.
Who are some of Rockwell Medical's key competitors?
Some companies that are related to Rockwell Medical include AxoGen (AXGN), TransMedics Group (TMDX), Cutera (CUTR), BioLife Solutions (BLFS), Viewray (VRAY), Stereotaxis (STXS), Zynex (ZYXI), Semler Scientific (SMLR), BioSig Technologies (BSGM), Fonar (FONR), electroCore (ECOR), Edap Tms (EDAP), Second Sight Medical Products (EYES), Fc Global Realty (FCRE) and Soleno Therapeutics (SLNO).
What other stocks do shareholders of Rockwell Medical own?
Who are Rockwell Medical's key executives?
Rockwell Medical's management team includes the folowing people:
- Mr. Stuart Paul, Pres, CEO & Director (Age 59)
- Mr. Angus W. Smith, Chief Financial Officer (Age 36)
- Dr. Ajay Gupta, Chief Scientific Officer & Member of Scientific Advisory Board (Age 61)
- Mr. Michael DeYoung, VP of Operations
- Mr. David J. Kull, Principal Accounting Officer, Sec. & Controller (Age 51)
Who are Rockwell Medical's major shareholders?
Rockwell Medical's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (6.36%), Vanguard Group Inc. (4.96%), Perceptive Advisors LLC (2.35%), Northern Trust Corp (1.09%), Luminus Management LLC (0.66%) and D. E. Shaw & Co. Inc. (0.54%). Company insiders that own Rockwell Medical stock include Angus W Smith, David S Richmond and Stuart M Paul. View Institutional Ownership Trends for Rockwell Medical.
Which institutional investors are selling Rockwell Medical stock?
RMTI stock was sold by a variety of institutional investors in the last quarter, including Parametric Portfolio Associates LLC, Corient Capital Partners LLC, Perritt Capital Management Inc. and Northern Trust Corp. View Insider Buying and Selling for Rockwell Medical.
Which institutional investors are buying Rockwell Medical stock?
RMTI stock was bought by a variety of institutional investors in the last quarter, including Perceptive Advisors LLC, Vanguard Group Inc., Luminus Management LLC, BlackRock Inc., Monashee Investment Management LLC, Wells Fargo & Company MN, HBK Investments L P and Jane Street Group LLC. Company insiders that have bought Rockwell Medical stock in the last two years include Angus W Smith, David S Richmond and Stuart M Paul. View Insider Buying and Selling for Rockwell Medical.
How do I buy shares of Rockwell Medical?
Shares of RMTI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Rockwell Medical's stock price today?
One share of RMTI stock can currently be purchased for approximately $3.33.
How big of a company is Rockwell Medical?
Rockwell Medical has a market capitalization of $191.71 million and generates $63.39 million in revenue each year. The company earns $-32,130,000.00 in net income (profit) each year or ($0.47) on an earnings per share basis. Rockwell Medical employs 269 workers across the globe.View Additional Information About Rockwell Medical.
What is Rockwell Medical's official website?
How can I contact Rockwell Medical?
Rockwell Medical's mailing address is 30142 S WIXOM RD, WIXOM MI, 48393. The company can be reached via phone at 248-960-9009 or via email at [email protected]
MarketBeat Community Rating for Rockwell Medical (NASDAQ RMTI)
MarketBeat's community ratings are surveys of what our community members think about Rockwell Medical and other stocks. Vote "Outperform" if you believe RMTI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RMTI will underperform the S&P 500 over the long term. You may vote once every thirty days.
